EP2685956A1 - Conditionnement pour produits pharmaceutiques unitaires - Google Patents
Conditionnement pour produits pharmaceutiques unitairesInfo
- Publication number
- EP2685956A1 EP2685956A1 EP12714803.9A EP12714803A EP2685956A1 EP 2685956 A1 EP2685956 A1 EP 2685956A1 EP 12714803 A EP12714803 A EP 12714803A EP 2685956 A1 EP2685956 A1 EP 2685956A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- closure member
- glued
- cell
- packaging according
- area
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
- A61J1/035—Blister-type containers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
- B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
- B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
- B65D75/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
- B65D75/325—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet being recessed, and the other being a flat not- rigid sheet, e.g. puncturable or peelable foil
- B65D75/327—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet being recessed, and the other being a flat not- rigid sheet, e.g. puncturable or peelable foil and forming several compartments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1412—Containers with closing means, e.g. caps
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D2575/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes or webs of flexible sheet material, e.g. in folded wrappers
- B65D2575/52—Details
- B65D2575/58—Opening or contents-removing devices added or incorporated during package manufacture
- B65D2575/586—Opening or contents-removing devices added or incorporated during package manufacture with means for reclosing
Definitions
- the invention relates to packages for unitary pharmaceutical products.
- the invention also relates to methods for taking at least one unitary pharmaceutical product.
- Packaging for pharmaceutical products comprising a receiving element, also called a blister, having a plurality of cells each defining an internal space configured to receive a pharmaceutical product, and an orifice opening into each internal space.
- a covering element is fixed on this blister to cover the cells.
- the cover member generally formed of a foil of aluminum, is disposed at the openings and is configured to be torn or removed to extract the pharmaceutical product in the cell, for example by action of a patient wanting to consume only a fraction of the drug product. The cell is then opened due to tearing or removal of a portion of the foil forming a lid.
- this remaining fraction may escape and the patient may lose it.
- the object of the invention is to provide a package which solves the problem mentioned above and which is simple, convenient and economical.
- the invention thus has, in a first aspect, a packaging for unitary pharmaceutical products, comprising a receiving element of at least one unitary pharmaceutical product, having at least one cell defining an internal space configured to accommodate said at least one unitary pharmaceutical product and an orifice opening into said internal space; and a cover member of said socket secured to said receiving member at said port and configured to be torn or removed to extract said pharmaceutical product disposed in said cell, said cell then being open; characterized in that it comprises a repositionable temporary closure member configured such that it has a predetermined initial position from which it can be removed and at least one temporary closure position in which said closure member is fixed temporarily on said receiving element around said orifice into which said inner space of said previously opened cell opens; said determined initial position being distinct from said at least one closure position and said temporary closure member has a sealing portion at least partially glued.
- a patient only wanting to consume a fraction of a unitary pharmaceutical product present in the internal space of the cell has the ability to safely store the unused fraction of the pharmaceutical product in the same internal space, originally intended for the entire pharmaceutical product. For this, it is sufficient for the patient to introduce the unused fraction of the pharmaceutical product into the internal space of the cell, to remove the repositionable temporary closure member from its determined initial position and to reposition the closure member temporary in its temporary filling position, that is to say opposite the same cell and the same fraction of unused pharmaceutical product, around the orifice.
- the temporary closure member forms a temporary seal disposed in place of another initial seal formed by the covering element.
- the packaging according to the invention thus has a simple and convenient secure structure, both in design and in use.
- said closure portion is provided with at least one glued area and at least one non-glued area;
- said glued zone has an annular shape and said non-glued zone has a rectangular shape
- said non-glued area is central on the sealing portion; said glued zone surrounds said non-glued zone;
- said glued area has the shape of a rectangle ring having a width in the range [10mm; 25mm], a length in the range [20mm; 35mm] and a thickness in the range [1mm; 10mm];
- said non-glued area has a width in the range [5mm; 20mm] and a length in the range [10mm; 30mm];
- said glued and non-glued areas are configured so that the area of the glue area is from about 25% to about 75% of the area of the sealing portion;
- said packaging comprises an interlayer protection sheet covering said non-bonded zone in said determined initial position of said closure member
- Said temporary closure member comprises a gripping portion projecting from the sealing portion
- said gripping portion is unsized
- said gripping portion has a width in the range [2mm; 10mm] and a length in the range [5mm; 20mm];
- the glued portion is provided with a food glue
- said temporary closure member is disposed on said element for receiving at least one pharmaceutical product when said temporary closure member is in its initial determined position;
- - Said packaging comprises a box for receiving said receiving element of at least one pharmaceutical product, said temporary closure member being disposed on said box when said temporary closure member is in its initial determined position.
- the subject of the invention is also, in a second aspect, a process for taking at least one unitary pharmaceutical product as described above placed in the internal space of a cell of a reception element of a packaging, comprising the following steps: extracting said at least one pharmaceutical unitary product from said receiving element by tearing or removal of a covering element fixed on said receiving element at an orifice into which said internal space of said cell opens, the cell thus being opened ;
- the method according to the invention is particularly simple and convenient to implement.
- FIG. 1 shows, schematically in perspective, a packaging according to the invention, comprising a box of which a receiving element of at least one pharmaceutical product is partially out and on which is disposed a repositionable temporary sealing member;
- FIG. 2 shows schematically in perspective, a user in the process of repositioning the temporary closure member of Figure 1 on said receiving member of Figure 1;
- FIG. 3 is a view similar to that of Figure 1 except that the temporary shutter member is positioned on the receiving member;
- - Figure 4 shows schematically the temporary closure member of Figures 1 to 3 taken separately;
- FIG. 5 shows schematically in perspective, a packaging according to a second embodiment of the invention
- FIG. 6 is a view similar to that of Figure 5 but for an alternative embodiment of the closure member
- FIG. 7 shows, schematically and partially, a packaging according to a third embodiment of the invention.
- Figure 8 schematically shows the temporary closure member of Figure 7 taken alone.
- FIG. 1 illustrates a package 1 for unitary pharmaceutical products 2 (shown in broken lines) in blister pack 3, which is adapted to be introduced and removed from a box 4 forming this package 1.
- Unit pharmaceutical products 2 are generally in the form of capsules, tablets or granules.
- These unitary pharmaceutical products 3 can be divided into several fractions.
- These pharmaceutical products 2 are packaged in the blister 3, which forms a receiving element and which comprises a plastic base 5 having protuberances 6, which each form a cell 7 defining an internal space 8 configured to receive a pharmaceutical product 2.
- the internal space 8 of each cell 7 opens into an orifice 9.
- Each cell 7 here has an oblong contour and a bowl bottom.
- the blister 3 comprises a covering element 10 formed by a film here made of metal, for example aluminum, covering the underside of the base 5, that is to say being disposed at the level of the orifices 9 in order to close each cell 7 for maintain pharmaceutical products 2 inside these cells 7.
- a covering element 10 formed by a film here made of metal, for example aluminum, covering the underside of the base 5, that is to say being disposed at the level of the orifices 9 in order to close each cell 7 for maintain pharmaceutical products 2 inside these cells 7.
- the metal film forms a plurality of lids each for a cell 7.
- This metal film is sufficiently fine for easy extraction of each unitary pharmaceutical product 2 by tearing the film by the action of an external extraction force of the unitary pharmaceutical product 2.
- the box 4 has a belt 11 formed by an upper face 12, a lower face 13 opposite to the upper face 12, a front face 14 and a bottom face 15 opposite to the end face 14.
- the upper face 12 faces, in a substantially parallel manner, the lower face 13 and the front face 14 is also opposite, substantially parallel to the bottom face 15.
- This box 4 has, in addition, a first flap 16 for opening / closing this box 4 and a second flap 17 for opening / closing this box 4.
- first and second flaps 16 and 17 in a closed configuration, obstruct the space defined inside the box 4 by the belt 11, with this space which is partially occupied by pharmaceutical products 2 in blister packs 3 and by a instructions for use (not shown).
- the first and second flaps 16 and 17 are articulated by a respective edge to the lower face 13.
- first and second flaps 16 and 17 are arranged facing one another, substantially parallel.
- the flap 17 is in its closed configuration while the flap 16 is in an open configuration.
- This flap 16 has a side wall 18 attached by a first end to the lower face 13 and a flap portion 19 attached by one end to a second end of the side wall 18, the second wall end 18 which is opposite the first end of this wall 18.
- the flap portion 19 is adapted to be inserted into the interior space of the box 4 when the flap 16 is in its closed configuration.
- This box 4 is made of cardboard material and formed in one piece by cutting a cardboard flank.
- This box 4 further has, on its upper face 12, a first zone for receiving a sticker 20 on which are mentioned administrative information useful for example for the reimbursement of pharmaceutical products 2 included in the box 4.
- This box 4 comprises a repositionable temporary closure member 22, here in the form of a label placed by gluing on a second zone of the upper face 12 of the box 4.
- the repositionable temporary closure member 22 is in a predetermined initial position from which it can be removed by detachment.
- This temporary closure member 22 also called a label, has a sealing portion 23 and a gripping portion 24 projecting from the sealing portion 23.
- Figure 3 is similar to Figure 1, except that the closure member 22 is repositioned on the blister 3 at an orifice 9 of a cell 7 previously opened.
- This closure member 22 thus forms a seal blocking this orifice 9.
- the closure member 22 is then in a temporary closure position which is distinct from the determined initial position illustrated in FIG. 1.
- closure member 22 will now be described in detail with reference to FIG. 4.
- the closing portion 23 of this member 22 has a glued area 25 and a non-glued area 26.
- the glued zone 25 here has a rectangle annular shape (whose corners are rounded) and the non-glued zone 26 here has a rectangular shape (whose corners are also rounded) located centrally in the closing portion 23.
- the glued zone 25 surrounds the non-glued zone 26.
- the glued area 25 has a first side 30, a second side 31 opposite the first side 30, a third side 32 and a fourth side 33 opposite the third side 32.
- the glued area 25 is provided with a food glue.
- the unsized area 26 has a first side 35, a second side 36 opposite the first side 35, a third side 37 and a fourth side 38 opposite the third side 37.
- the non-glued area 26 is intended to be disposed facing the orifice 9 of a cell 7 previously opened blister 3 when a patient positions the closure member 22 in its position of temporary closure.
- the glued zone 25 and the non-glued zone 26 each have an outer contour of the same general shape.
- the outer contour of the non-glued zone 26 coincides with the internal contour of the glued zone 25.
- first sides 30 and 35 respectively of the glued and non-glued areas 25 and 26 are arranged facing each other
- second sides 31 and 36 respectively of the glued and non-glued areas 25 and 26 are arranged facing each other
- third sides 32 and 37 respectively of the glued and non-glued areas 25 and 26 are arranged facing each other
- fourth sides 33 and 38 respectively of the glued and non-glued areas 25 and 26 are arranged facing each other.
- the glued zone 25 has a width a1 approximately equal to 14mm, a length b1 approximately equal to 23mm, a first thickness e1 (along its length b1) approximately equal to 3mm and a second thickness f1 (the along its width a1) approximately equal to 5mm.
- the non-glued area 26 has a width c1 approximately equal to 8mm and a length d1 approximately equal to 13mm.
- the glued zone 25 extends over a surface representing approximately 32% of the surface of the sealing portion 23.
- the gripping portion 24 extends projecting from the second side 31 of the glued area 25 of the sealing portion 23. This gripping portion 24 is unsized.
- the gripping portion 24 here has a substantially rectangular shape (two free corners are rounded) and is unsized.
- the gripping portion 24 has a width h1 approximately equal to 8mm, as the width c1 of the non-glued area 26, and a length g1 approximately equal to 4mm.
- the closure member 22 thus has a total length of approximately 27 mm and a width corresponding to the width a1 of the glued area 25 which is approximately equal to 14 mm.
- the patient reintroduces the unconsumed fraction of the pharmaceutical product 2 into the internal space 8 of the cell 7 previously opened.
- the patient catches the gripping portion 24 of the closure member 22 and peels off the closure portion 23 of this closure member 22 from the upper face 12 of the box 4.
- the closure member 22 is removed from its determined initial position.
- the patient repositions the closure member 22 on the underside of the base 5 of the blister 3, at the orifice 9 of the previously opened cell in which the unused fraction is disposed. of the pharmaceutical product 2 fractionated ( Figure 2), to close the internal space 8 of the cell 7.
- the closure element 22 is then in a temporary closure position on the blister 3.
- This closure member 22 is arranged so that it completely covers the orifice 9 of the cell 7 in order to prevent the remaining fraction of the pharmaceutical product 2 from escaping.
- the closure member 22 is disposed substantially in the same direction as the longitudinal direction of the cell 7, here at an angle with respect to the longitudinal edges of the base 5 of the blister 3.
- the patient can then reintroduce the blister 3 into the box 4 with the remaining fraction of the drug product 2 which is stored safely.
- the patient can then re-loosen the temporary closure member 22 to take the remaining fraction of the pharmaceutical product 2 and re-position by gluing the temporary closure member 22 on the box 4 or put it back in its temporary filling position, as desired.
- the patient can again releaser this closure member 22 if it takes up only a fraction of another pharmaceutical unit and secure the remaining fraction by repositioning the closure member 22 next to the new open cell.
- FIG. 5 illustrates a packaging similar to that of FIGS. 1 to 3, except that the closure member 22 (identical to that of FIGS. 1 to 4) is in a determined initial position different from the initial position determined of the shutter member of FIGS. 1 to 4.
- the closure member 22 is shown in broken lines since it is on the bottom of the base 5 of the blister 3.
- the closure member 22 is shown in two positions, the central one corresponding to its determined initial position in which it does not covers no orifice 9, and the other side corresponding to its temporary sealing position in which it covers an orifice 9.
- the closure member 22 In its determined initial position, the closure member 22 is situated directly on the blister 3, unlike FIGS. 1 to 3, where the closure member 22 is located, in its determined initial position, on the box 4. .
- the blister 3 of FIG. 5 has a central zone adapted to receive the closure member 22, without the latter hindering the extraction of one of the unitary pharmaceutical products 2 located in the cells 7 of the blister 3.
- the closure member 22 is placed by gluing on the blister 3 by means of its bonded zone 25 located on the closing portion 23.
- This closure member 22 further has a gripping portion 24 projecting for its withdrawal from its initial position determined on the blister 3 to the temporary closure position shown in this same figure 5.
- closure member 22 In this position of temporary closure, the closure member 22 is arranged differently with respect to Figures 2 and 3 since it has its long sides substantially parallel to the longitudinal edges of the blister 3. The closure member 22 n ' so is not inclined.
- the remaining fraction of the pharmaceutical product 2 is opposite the non-glued zone 26 of the closure member 22 and this closure member 22 completely covers the orifice 9 of the cell 7 in which the fraction is located. remaining pharmaceutical product 2.
- FIG. 6 illustrates a closure member 122 according to an alternative embodiment of the closure member 22 of FIGS. 1 to 5.
- the closure member 122 differs from the closure member 22 only in its dimensions.
- the closure member 122 comprises a sealing portion 123 provided with a glued area 125 and a non-glued area 126; and a gripping portion 124 projecting from the sealing portion 123.
- the glued zone 125 has a width a2 approximately equal to 21 mm and a constant thickness e2 along its periphery approximately equal to 4 mm.
- the non-glued area 126 has a width c2 approximately equal to 13mm and a length d2 approximately equal to 18mm.
- the gripping portion 124 has a length g2 approximately equal to 4mm and a width h2 approximately equal to 10mm.
- the closure member 122 thus has a total length i2 approximately equal to 30mm and a total width equal to the width a2 of the glued area 125 which is approximately equal to 21mm.
- the surface of the glued zone 125 thus represents approximately 43% of the surface of the sealing portion 123.
- Figures 7 and 8 illustrate a third embodiment of the packaging.
- Figure 7 illustrates a package 201 having a box 204, a temporary closure member 222 (shown in detail in Figure 8) and a blister (not shown) having a plurality of unitary pharmaceutical products (not shown).
- the box 204 and the blister of FIG. 7 are identical to the box 4 and the blister 3 of FIGS. 1 to 4.
- the closure member 222 of FIGS. 7 and 8 is also identical to the closure member 22 of FIGS. 1 to 4, except that an intermediate protection sheet 245 is interposed between this member of FIG. shutter 222 and the upper face 212 of the box 204 in the determined initial position of the member 222.
- This interlayer protection sheet 245 has larger dimensions than the dimensions of the non-glued area 226 (shown in broken lines in FIG. 8) of the closing portion 223 of the member 222. Thus, the peripheral edge of this sheet 245 is placed by gluing on the glued area 225 of the closure portion 223 of the member 222, so that the sheet 245 covers the non-glued area 226 and isolates the latter from impurities that may be present on the box 204.
- the spacer sheet 245 remains attached to the glue area 225.
- the patient must then remove the intermediate sheet 245 before repositioning the closure member 222 on the blister in a closed position of a previously opened cell.
- the repositionable temporary sealing member has much larger dimensions, for example close to those of the blister;
- the repositionable temporary sealing member comprises a glued area which has a width in the range [10mm; 25mm], a length in the range [20mm; 35mm], a thickness in the range [1mm; 10mm]; and / or a non-sized area having a width in the range [5mm; 20mm] and a length in the range [10mm; 30mm]; and / or a gripping portion having a width in the range [2mm; 10mm] and a length in the range [5mm; 20mm];
- the glued area has a semi-annular shape rather than an annular shape and the glued area only partially surrounds the non-glued area;
- the bonded area of the closure member has a surface which represents about 25% to about 75% of the surface of the closure portion of the closure member;
- the repositionable temporary closure member is completely glued; - The closing portion of the closure member is completely glued and the gripping portion is unsized;
- the glued area of the sealing member comprises a non-food glue
- the closing member in its determined initial position, is situated neither on the upper face of the box nor on the packaging, but rather on the lower face of the box, or on a user manual mentioning in particular the dosage associated with the pharmaceutical products of the packaging, or on a support plate inserted freely in the box or glued (so that it is peelable) in the box;
- one side of the interlayer sheet is glued to the box, at the level of the receiving zone of the closure member so that the non-glued area of the latter is opposite the sheet in its determined initial position; and the sheet remains on the box when the patient removes the closure member from its determined initial position;
- the two faces of the interlayer sheet are sized and this sheet has dimensions equal to those of the non-bonded area of the sealing portion, or larger;
- the shutter member has a different shape of the closure members 22 and 122 described in Figures 1 to 6, for example a circle or diamond shape;
- the packaging comprises several repositionable temporary sealing devices
- the blister does not have a plastic base and an aluminum film, but it is rather entirely made of metal material, for example aluminum, or plastic material;
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Composite Materials (AREA)
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Packages (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1152202A FR2972629B1 (fr) | 2011-03-17 | 2011-03-17 | Conditionnement pour produits pharmaceutiques unitaires |
PCT/FR2012/050561 WO2012123689A1 (fr) | 2011-03-17 | 2012-03-16 | Conditionnement pour produits pharmaceutiques unitaires |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2685956A1 true EP2685956A1 (fr) | 2014-01-22 |
EP2685956B1 EP2685956B1 (fr) | 2016-02-03 |
Family
ID=45974424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP12714803.9A Active EP2685956B1 (fr) | 2011-03-17 | 2012-03-16 | Conditionnement pour produits pharmaceutiques unitaires |
Country Status (5)
Country | Link |
---|---|
US (1) | US9173812B2 (fr) |
EP (1) | EP2685956B1 (fr) |
JP (1) | JP6005077B2 (fr) |
FR (1) | FR2972629B1 (fr) |
WO (1) | WO2012123689A1 (fr) |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE8110654U1 (de) * | 1981-04-08 | 1981-07-30 | Josef Uhlmann Maschinenfabrik Gmbh + Co Kg, 7958 Laupheim | Durchdruckpackung fuer Tabletten o dgl |
DE3832083A1 (de) * | 1988-09-21 | 1990-03-22 | Hans Lobermeier | Blisterverpackung fuer kleine gegenstaende |
EP0712790B1 (fr) * | 1994-11-15 | 1999-02-03 | Alusuisse Technology & Management AG | Emballage de type blister |
DE202004006275U1 (de) * | 2004-04-21 | 2004-06-17 | Klocke Verpackungs-Service Gmbh | Verschließbare Tiefziehpackung |
GB2416758B (en) * | 2004-08-05 | 2007-10-24 | Surgichem Ltd | Seal |
DE102004047447B4 (de) * | 2004-09-30 | 2008-01-03 | Lts Lohmann Therapie-Systeme Ag | Peelfähige, kindesichere Verpackung für flache, biegsame Objekte, Verwendung dieser Verpackungen und Verfahren zum Verpacken von flachen, biegsamen Objekten |
US20070227931A1 (en) * | 2006-03-21 | 2007-10-04 | Shane Jeffrey A | Child-Resistant Wallet Package for Dosage Forms |
US7673752B2 (en) * | 2006-09-12 | 2010-03-09 | Navajo Manufacturing Company, Inc. | Drug card |
US7866476B2 (en) * | 2007-05-30 | 2011-01-11 | Walgreen Co. | Multi-dose blister card pillbook |
JP5408747B2 (ja) * | 2009-11-02 | 2014-02-05 | 日本たばこ産業株式会社 | 口腔用たばこ製品の包装容器 |
-
2011
- 2011-03-17 FR FR1152202A patent/FR2972629B1/fr not_active Expired - Fee Related
-
2012
- 2012-03-16 WO PCT/FR2012/050561 patent/WO2012123689A1/fr active Application Filing
- 2012-03-16 US US14/004,263 patent/US9173812B2/en not_active Expired - Fee Related
- 2012-03-16 JP JP2013558491A patent/JP6005077B2/ja not_active Expired - Fee Related
- 2012-03-16 EP EP12714803.9A patent/EP2685956B1/fr active Active
Non-Patent Citations (1)
Title |
---|
See references of WO2012123689A1 * |
Also Published As
Publication number | Publication date |
---|---|
JP6005077B2 (ja) | 2016-10-12 |
WO2012123689A1 (fr) | 2012-09-20 |
FR2972629B1 (fr) | 2014-07-25 |
FR2972629A1 (fr) | 2012-09-21 |
JP2014509536A (ja) | 2014-04-21 |
EP2685956B1 (fr) | 2016-02-03 |
US9173812B2 (en) | 2015-11-03 |
US20140001077A1 (en) | 2014-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2916156A1 (fr) | Procede pour la realisation d'un joint scellable pour l'obturation d'un recipient a fermeture par bouchon ou capsule | |
FR2772011A1 (fr) | Etui pour produits, et article obtenu | |
EP0406109A1 (fr) | Récipient thermoplastique à ouverture par pelage partiel d'un couvercle multicouche thermosoudé sur le rebord de ce dernier et film couvercles multicouches | |
BE1020393A3 (fr) | Machine d'emballage sous emballage coque et emballage coque. | |
EP0579714B1 (fr) | Dispositif d'ouverture d'un sac en materiau flexible pour l'emballage de produits compressibles | |
CA2780296A1 (fr) | Emballage d'un produit alimentaire portionnable | |
EP2685956B1 (fr) | Conditionnement pour produits pharmaceutiques unitaires | |
EP3144238B1 (fr) | Emballage et flan pour emballage avec dispositif d'ouverture perfectionné | |
EP0688294B1 (fr) | Suremballage de produits | |
WO2012076798A1 (fr) | Conditionnement pour produits pharmaceutiques sous blister | |
FR3105189A1 (fr) | Distributeur par écoulement gravitaire de produit en vrac | |
EP1379449B1 (fr) | Ensemble de distribution de produit fluide | |
EP2678239B1 (fr) | Tete de distribution de produit fluide. | |
WO2008099096A2 (fr) | Ensemble de distribution de produit fluide | |
EP1120356B2 (fr) | Emballage de distribution de produits en feuilles | |
EP2731888B1 (fr) | Organe de bouchage et distributeur comprenant un tel organe. | |
EP3044116B1 (fr) | Sachet refermable et procede de fabrication dudit sachet | |
EP1398277A1 (fr) | Blister sécurisé à usage pharmaceutique, plaquette et procédé de fabrication correspondants | |
FR3128699A1 (fr) | Étiquette de contention de rouleau de sacs comportant des liens de fermeture | |
EP4359314A2 (fr) | Dispositif de conditionnement d'une dose d'un produit solide ou pateux place dans un reservoir | |
EP0541762A1 (fr) | Emballage du type comprenant une poche interne souple et une enveloppe externe rigide et son procede de fabrication | |
WO2002081326A1 (fr) | Ensemble de distribution de produit fluide | |
FR2829472A1 (fr) | Emballage comportant un sachet et un cavalier informatif | |
WO2007060332A1 (fr) | Paquet d'articles comprenant un flanc couvrant les articles et un film enserrant le tout | |
FR2883555A1 (fr) | Ensemble configure pour obturer un orifice de distribution d'un dispositif de conditionnement et d'application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20130917 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
17Q | First examination report despatched |
Effective date: 20140625 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20150730 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 773318 Country of ref document: AT Kind code of ref document: T Effective date: 20160215 Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 5 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: FRENCH |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602012014380 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D Ref country code: NL Ref legal event code: MP Effective date: 20160203 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 773318 Country of ref document: AT Kind code of ref document: T Effective date: 20160203 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160504 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160203 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160203 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160203 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160503 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160203 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160603 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160203 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160203 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160603 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160203 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160203 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160203 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160331 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160203 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160203 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160203 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160203 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602012014380 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160203 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160203 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160203 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160203 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
26N | No opposition filed |
Effective date: 20161104 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160331 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160331 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160316 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 6 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160503 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160203 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160203 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 7 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160203 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20120316 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160316 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160203 Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160203 Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160203 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160203 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20210210 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20210308 Year of fee payment: 10 Ref country code: DE Payment date: 20210302 Year of fee payment: 10 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602012014380 Country of ref document: DE |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20220316 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220316 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220331 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221001 |